Alkermes ALKS
NASDAQ ALKS
$40.54 +0.02 (+0.05%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alkermes (ALKS) Depreciation and Depletion (2010 - 2012)

Updated

Alkermes (ALKS) posted Depreciation and Depletion of $31.1 million for FY2025, up 13.5% from $27.4 million in FY2024.

Analysis

Alkermes (ALKS) Depreciation and Depletion (2010 - 2012) Analysis & Trends

Since FY2010, Alkermes has reported Depreciation and Depletion for 16 years.

  • Annual Depreciation and Depletion shows a five-year compound annual growth rate of -6.0% (FY2020 to FY2025).
  • The FY2025 figure stands as the highest annual Depreciation and Depletion since FY2020.
  • Business Quant data shows ALKS's Depreciation and Depletion at $27.4 million in FY2024 (+6.6%), $25.7 million in FY2023 (-2.3%), $26.3 million in FY2022 (+12.9%) and $23.3 million in FY2021 (-45.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Alkermes 6.79 Bn 3.92 Bn 397.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 -4.75 Mn
Dec 31, 2011 20.87 Mn
Mar 31, 2011 2.49 Mn
Dec 31, 2010 2.15 Mn
API Access

Alkermes Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ALKS&period=max&api_key=YOUR_API_KEY